Inventor · disambiguated record
Andrew W. Roberts
Also filed as: ROBERTS ANDREW · ROBERTS ANDREW W · ROBERTS ANDREW WARWICK
3 granted patents·11 pending applications·11 citations·filing 2001–2025
71Inventor score
Top patents by PatentIndex Score
14 records- 0195US11110087B2Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitorGENENTECH INC·Filed 2021·Granted Sep 7, 2021·5 cites·29 claims
- 0294US11590128B2Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitorGENENTECH INC·Filed 2022·Granted Feb 28, 2023·3 cites·7 claims
- 0393US10993942B2Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitorGENENTECH INC·Filed 2020·Granted May 4, 2021·3 cites·30 claims
- 0487US2024000776A1Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitorGENENTECH INC·Filed 2023·Application pending·0 cites
- 0587US2024108616A1Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitorGENENTECH INC·Filed 2023·Application pending·0 cites
- 0684US2023226045A1Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitorGENENTECH INC·Filed 2023·Application pending·0 cites
- 0781US2022265642A1Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitorGENENTECH INC·Filed 2022·Application pending·0 cites
- 0878US2022211696A1Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitorGENENTECH INC·Filed 2021·Application pending·0 cites
- 0976US2025152582A1Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitorGENENTECH INC·Filed 2025·Application pending·0 cites
- 1049US2008286281A1Cd25 binding molecules for the use in the treatment of manifestations of rejection in transplantationFEUTREN GILLES·Filed 2008·Application pending·0 cites
- 1144US2010292200A1Methods for Modulating Apoptosis in PlateletsINST MEDICAL W & E HALL·Filed 2007·Application pending·0 cites
- 1242US2007275916A1Methods of Identifying Compounds Which Modulate Granulocite-Colony Stimulating Factor (G-Csf) Dependent Processes by Modulation of the Levels of Suppressor of Cytokine Signaling (Socs)INST MEDICAL W & E HALL·Filed 2004·Application pending·0 cites
- 1341US2006093604A1Method of treatment and prophylaxisINST MEDICAL W & E HALL·Filed 2003·Application pending·0 cites
- 1435US2001041179A1CD25 binding molecules for use in the treatment of manifestations of rejection in transplantationFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew W. Roberts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →